Daxor
DXR
6 hedge funds and large institutions have $596K invested in Daxor in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
220% more capital invested
Capital invested by funds: $186K → $596K (+$410K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
0.65% more ownership
Funds ownership: 0.53% → 1.18% (+0.65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$129K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$103K |
| 3 |
Renaissance Technologies
New York
|
+$26.9K |
| 4 |
PCM
Prelude Capital Management
New York
|
+$6.11K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.07K |
DXR Hedge Fund Activity: Q1 2020 in Review
6 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q1 2020, worth a combined $596K — up 220% from $186K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DXR positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Diametric Capital, opening a new position worth an estimated $129K. The largest seller was UBS Group, exiting entirely with an estimated $11K sold.
- 6 institutional investors held Daxor (DXR) as of Q1 2020, up from 4 in Q4 2019.
- Funds reported $596K of Daxor stock for Q1 2020, up 220% quarter-over-quarter.
- 3 funds opened new Daxor positions in Q1 2020 and 1 closed out, a net change of +2 holders.
- The largest Daxor buyer in Q1 2020 was Diametric Capital, an estimated $129K added.
- The largest Daxor seller in Q1 2020 was UBS Group, an estimated $11K sold.
Based on aggregated 13F filings for Q1 2020.